XML 73 R57.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity - Narrative (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Jul. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Purchases of treasury stock         $ 750.0 $ 188.7  
JPM Warrant Transactions | Senior Convertible Notes due 2023 | Senior Notes | Common Stock              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Exercise and settlement of warrants (in shares)     1.9        
Stock issued during period, shares, exercise and settlement of remaining warrants (in shares)   4.6          
2024 Share Repurchase Program              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Shares repurchased (in shares) 10.4            
Purchases of treasury stock $ 750.0            
Common Stock              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Exercise and settlement of warrants (in shares)     7.9   12.5    
Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (in shares)         1.5    
Common Stock | 2024 Share Repurchase Program              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock repurchase program, authorized amount             $ 750.0
Milestone Payments | Verily Life Sciences | Collaborative Arrangement              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (in shares)     1.5 3.7      
Restricted Stock Units (RSUs) and Performance Shares | Equity Incentive Plan 2015              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Unrecognized estimated compensation costs $ 253.2       $ 253.2    
Unrecognized compensation costs recognized weighted average period (in years)         1 year 9 months 18 days